This work supported these speculations, because PDE3B expression was associated with CDDP resistance in human cancer cells and also showed that inhibiting the PDE3B gene by gene silencing and cilostazol results in enhanced CDDP responses in various human cancer cell lines in vitro and in vivo. The gene discussed is PDE3B; the disease is cancer.